AQ eTMF holds the trial master file on the same study record as the site file, the pharmacy file and CAPA. Every document files to the TMF Reference Model by study, country and site, and completeness shows on any day a sponsor, auditor or MHRA inspector asks.
Sponsors answer for the TMF even when CROs and sites file most of it. Documents arrive through portals, shared drives and email, and the TMF team learns what is missing at the point of review.
Documents reach the TMF weeks after the activity they record. The file shows the study as it was, and contemporaneous evidence is lost.
TMF teams count expected against filed by hand, at review time. The count is out of date the day after it is made.
QC queries and missing documents move into email and side trackers. The trail from finding to fix breaks before quality sees it.
Sponsor, CRO and site copies of the same record drift in version and location. Close-out starts with reconciliation.
AQ eTMF covers the TMF from study set-up to archive. Each control writes to the same record, so completeness, QC and audit evidence always describe the same documents.
AQ eTMF files every document to the CDISC TMF Reference Model: zone, section and artifact, by study, country and site.
Every document enters the file with a location, a classification and an audit record.
TMF health shows by study and site, against what the study expects.
Each study carries its own list of expected documents before anyone uploads one.
Every document runs the same lifecycle: Draft, Pending QC, In QC, Final, Superseded.
AQ eTMF records every action on a document as it happens.
Access follows role, study, country and site.
Approvals and signatures sit on the document they authorise.
The TMF stays readable and protected for the full retention period.
AQ eTMF and AQ eISF share one study record. Sponsors see what they need, sites work in what they own, and each document exists once.
Study, countries, sites and milestones come from AQ CTMS, so AQ eTMF measures completeness against the study as it runs.
Study, countries, sites and milestones come from AQ CTMS, so AQ eTMF measures completeness against the study as it runs.
Site documents index into the TMF automatically as the current version. Sponsor and site file each record once.
Site documents index into the TMF automatically as the current version. Sponsor and site file each record once.
Pharmacy records file to the same TMF structure as sponsor and site documents.
Pharmacy records file to the same TMF structure as sponsor and site documents.
Study 001 · one study recordTMF · eISF · Pharmacy · each document exists onceEvery connection is native to AQ Platform and runs from the first study.
AQ eTMF checks each signature against the live delegation log, so only a currently authorised delegate can sign.
AQ eTMF checks each signature against the live delegation log, so only a currently authorised delegate can sign.
Staff training records link to the study, and SOPs stay under quality control.
Staff training records link to the study, and SOPs stay under quality control.
QC findings and unresolved gaps become CAPA records, with owner, evidence and resolution history on one workflow.
QC findings and unresolved gaps become CAPA records, with owner, evidence and resolution history on one workflow.
AQ eTMF runs the hub-and-spoke model directly. A coordinating centre sees completeness, delegation, quality and readiness across every site from one view, and each site works in its own record.
Coordinating centreEvery TMF document passes through the same four stages. Each stage records who acted, when, and what changed.
TMF and quality leads open one view to answer the questions a sponsor or inspector asks first.
These capabilities are in development. Each one is standard in leading eTMF products, and each one runs on the same study record as the rest of AQ eTMF.
AQ eTMF reads each uploaded document, proposes its zone, section and artifact, and fills the metadata for a person to confirm.
In developmentAQ eTMF indexes every document, scanned files included, so teams search by content as well as by metadata.
In developmentAn open API connects AQ eTMF to EDC, CTMS and institutional systems from other suppliers.
In developmentStudy events in EDC and REDCap update the TMF.
In developmentTeams send documents to a study address, and each one arrives in the file for classification and QC.
In developmentAQ eTMF exports the full TMF in the industry exchange format, so a sponsor can take the file from a CRO, or move it to another system.
In developmentQC effort follows document risk, with sampling rules set by the sponsor.
In developmentAQ eTMF tracks expiry dates on CVs, GCP certificates and laboratory normal ranges, and alerts the owner before they lapse.
In developmentIn development. Ask us for the current plan.
Most TMF teams choose between four kinds of tool. AQ eTMF is the only one that carries the site file and the pharmacy file on the same record as the TMF.
Compared by category of tool. Based on AQ’s review of published product information, June 2026.
AQ eTMF is built around these standards. Each organisation remains responsible for validating its own use.
An electronic trial master file is the system that holds the essential records of a clinical trial and shows, for each record, who filed it, who approved it and what changed. AQ eTMF files those records to the CDISC TMF Reference Model by study, country and site, tracks completeness against what the study expects, and keeps an immutable audit trail on every document.
An electronic trial master file is the system that holds the essential records of a clinical trial and shows, for each record, who filed it, who approved it and what changed. AQ eTMF files those records to the CDISC TMF Reference Model by study, country and site, tracks completeness against what the study expects, and keeps an immutable audit trail on every document.
The eTMF is the sponsor’s file for the whole trial. The eISF is each site’s own file. AQ eTMF and AQ eISF share one study record, so site documents index into the TMF as the current version, and sponsor and site hold one record of each document.
The eTMF is the sponsor’s file for the whole trial. The eISF is each site’s own file. AQ eTMF and AQ eISF share one study record, so site documents index into the TMF as the current version, and sponsor and site hold one record of each document.
AQ eTMF creates a placeholder for every document the study expects, from study-defined lists and milestones. Completeness is the share of placeholders filled with a document that has passed QC, shown by trial, country, site and zone with RAG status, alongside timeliness and quality scores.
AQ eTMF creates a placeholder for every document the study expects, from study-defined lists and milestones. Completeness is the share of placeholders filled with a document that has passed QC, shown by trial, country, site and zone with RAG status, alongside timeliness and quality scores.
AQ CTMS and AQ eTMF share one study record, so the study, sites and milestones reach the TMF directly. A CTMS from another supplier needs an interface, and an interface between two validated systems is itself a computerised system that needs its own validation evidence. An open API for other suppliers’ systems is in development.
AQ CTMS and AQ eTMF share one study record, so the study, sites and milestones reach the TMF directly. A CTMS from another supplier needs an interface, and an interface between two validated systems is itself a computerised system that needs its own validation evidence. An open API for other suppliers’ systems is in development.
The best eTMF software for UK clinical research files to the TMF Reference Model, tracks completeness continuously, gives MHRA inspectors read-only access to the live file and states where its data sits. Ask every supplier for validation evidence for the release you will use. AQ eTMF meets the first four, and keeps the platform and study record in Microsoft Azure UK regions with DSPT Standards Met for 2026.
The best eTMF software for UK clinical research files to the TMF Reference Model, tracks completeness continuously, gives MHRA inspectors read-only access to the live file and states where its data sits. Ask every supplier for validation evidence for the release you will use. AQ eTMF meets the first four, and keeps the platform and study record in Microsoft Azure UK regions with DSPT Standards Met for 2026.
Look for a reference-model structure, expected document lists, version control with locked final documents, duplicate detection, QC routing with queries, electronic signatures with meaning captured, an immutable audit trail, and retention controls with legal hold. AQ eTMF holds all of these on the same record as the site file, the pharmacy file and CAPA.
Look for a reference-model structure, expected document lists, version control with locked final documents, duplicate detection, QC routing with queries, electronic signatures with meaning captured, an immutable audit trail, and retention controls with legal hold. AQ eTMF holds all of these on the same record as the site file, the pharmacy file and CAPA.
AQ eTMF gives inspectors scoped, read-only, time-limited access to the live TMF and logs every document they open or download. Readiness scores show completeness, quality, open queries and overdue gaps for each trial and site, and an archive export carries an integrity manifest for each file.
AQ eTMF gives inspectors scoped, read-only, time-limited access to the live TMF and logs every document they open or download. Readiness scores show completeness, quality, open queries and overdue gaps for each trial and site, and an archive export carries an integrity manifest for each file.
Yes. AQ eTMF scopes filing, completeness and access to study, country and site, and every CRO files to the sponsor’s structure. Coordinating centres in hub-and-spoke networks see every site in one view while each site works in its own record.
Yes. AQ eTMF scopes filing, completeness and access to study, country and site, and every CRO files to the sponsor’s structure. Coordinating centres in hub-and-spoke networks see every site in one view while each site works in its own record.
The sponsor and the chief investigator of a clinical trial of an investigational medicinal product keep the trial master file for at least 25 years, starting the day after the trial ends. Regulation 31A of the UK clinical trials regulations sets this period, as amended from 28 April 2026. The sponsor keeps the file for at least 2 more years after a UK marketing authorisation is granted, where the trial supports that application when the 25 years run out. AQ eTMF supports 25-year retention with configurable retention policies, legal hold and destruction certificates.
The sponsor and the chief investigator of a clinical trial of an investigational medicinal product keep the trial master file for at least 25 years, starting the day after the trial ends. Regulation 31A of the UK clinical trials regulations sets this period, as amended from 28 April 2026. The sponsor keeps the file for at least 2 more years after a UK marketing authorisation is granted, where the trial supports that application when the 25 years run out. AQ eTMF supports 25-year retention with configurable retention policies, legal hold and destruction certificates.
The platform and study record are hosted in Microsoft Azure UK regions. AQ Platform holds DSPT Standards Met status for 2026 and Cyber Essentials certification. Access is role-based, and every action on a document sits in an immutable audit trail.
The platform and study record are hosted in Microsoft Azure UK regions. AQ Platform holds DSPT Standards Met status for 2026 and Cyber Essentials certification. Access is role-based, and every action on a document sits in an immutable audit trail.
Thirty minutes on your own studies — documentation, study activity, quality processes and pharmacy, in one governed record.
Practical walkthroughs aligned with active research delivery.
We’ll only use your details to arrange your demo and
send relevant AQ updates. No spam.
Pick a module, your organisation type, or both — we'll match the guides and email them to you.
Try one filter at a time, or clear to see all guides.

✓ Written for first-in-human & Phase 1 sites
✓ Inspection-ready checklists & templates
✓ Aligned to MHRA, FDA & EU Annex 11